Quince Therapeutics, Inc. Common Stock

QNCX XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

21M

Short interest (May 15)

10.8%

Net Short (Jun 03 ): 0.1%

Borrow Fee

47.87%

↑ 9.7%

Available Shares

100K

↓ 63.0%

Price Chart

Company Overview

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001662774

Asset Type: CS

Market Data

Market Cap: $20,537,219

Employees: 38

Status: Active

Short Interest

Current Borrow Fee 47.87%

Range: 38.68% - 47.87%

Available Shares 100K

Range: 55K - 100K

Recent Changes

Fee Change: ↑ 13.2%

Available Change: ↓ 3.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime